It’s hard to find a pharmaceutical executive who does not believe it’s important to have a robust omnichannel strategy for the organization today. However, the gap between the belief in omnichannel and execution remains. What are the hurdles to success? What’s working today in omnichannel HCP engagement? And what role will AI and machine learning play in pharma’s commercial future?
Utilizing a mix of qualitative and quantitative research methodologies, Aktana, in collaboration with the DHC Group, got the answers to these questions and more by speaking to over 50 pharmaceutical industry executives in this overview of omnichannel innovation and strategy.
Download the full report here.